A recent study found that people with the corona virus are more likely to have mental health problems.
The study was published in the journal Wednesday P.M.J. Scientific records of approximately 154,000 people infected with Govit-19 and their experience after recovering from an initial infection compared it to non-infected individuals.
The study included only patients who had not been diagnosed or treated for mental illness for at least two years before being exposed to the corona virus, allowing researchers to focus on psychiatric diagnoses only after being infected with the virus.
The study found that people with Covit-19 were 39 percent more likely to develop depression and 35 percent more likely to develop anxiety within a few months of exposure to the disease, compared to those without covid during the same period.
Govt patients were 38 percent more likely to be diagnosed with depression and 41 percent more likely to have sleep disorders than non-sufferers.
Dr. Paul Harrison, a professor of psychiatry at Oxford University (not involved in the study), told the newspaper:The New York TimesThese findings reinforce the hypothesis that there is something about the corona virus that can cause common mental health problems, including a 2021 study he authored.
The data do not indicate that most Kovit patients will develop psychological symptoms because the proportion of people who are susceptible to these symptoms is only 4.4 to 5.6 percent of those included in the study.
They, in particular, complained of depression, anxiety or stress, and adjustment disorders.
Researchers have also found that people with goiter are 80 percent more likely to develop cognitive problems such as brain fog, confusion and forgetfulness than those without covit.
The study found that they were 34 percent more likely to have opioid use disorders “probably due to prescribed pain medications” and 20 percent more likely to have non-opioid use disorders, including alcoholism.
The study found that after being infected with COVID-19, people were 55 percent more likely to take antidepressants and 65 percent more likely to take antidepressants compared to those without COVID-19.
